Your browser doesn't support javascript.
loading
Neurodevelopmental outcomes and in-utero antiretroviral exposure in HIV-exposed uninfected children.
Piske, Micah; Budd, Matthew A; Qiu, Annie Q; Maan, Evelyn J; Sauvé, Laura J; Forbes, John C; Alimenti, Ariane; Janssen, Patricia; Côté, Hélène C F.
Afiliação
  • Piske M; Department of Pathology & Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Budd MA; Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK.
  • Qiu AQ; Department of Pathology & Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Maan EJ; Oak Tree Clinic, BC Women's Hospital and Health Centre.
  • Sauvé LJ; Oak Tree Clinic, BC Women's Hospital and Health Centre.
  • Forbes JC; Oak Tree Clinic, BC Women's Hospital and Health Centre.
  • Alimenti A; Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.
  • Janssen P; Oak Tree Clinic, BC Women's Hospital and Health Centre.
  • Côté HCF; Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.
AIDS ; 32(17): 2583-2592, 2018 11 13.
Article em En | MEDLINE | ID: mdl-30134292
ABSTRACT

OBJECTIVES:

To assess and compare neurodevelopmental disorders in HIV-exposed uninfected (HEU) and HIV-unexposed uninfected (HUU) children in British Columbia, Canada. To determine associations between these outcomes and in-utero exposure to antiretroviral drugs.

DESIGN:

Retrospective controlled cohort study.

METHODS:

Data were collected on 446 HEU children and 1323 HUU children (matched ∼1  3 for age, sex, and geocode) born between 1990 and 2012. Multivariable logistic regressions determined odds ratios of neurodevelopmental disorder diagnoses.

RESULTS:

HEUs had three times higher odds of being born preterm (P < 0.0001), and a more than two-fold increase in odds for autism, disturbance of emotions, hyperkinetic syndrome, and developmental delay compared with matched HUUs (P < 0.02) in unadjusted analysis. This association was reduced [adjusted neurodevelopmental disorder odds ratio (AOR) = 1.67; 95% confidence interval 1.12-2.48; P = 0.011] after adjusting for maternal substance use and/or smoking (children born after April 2000). Regardless of antiretroviral exposure type (i.e. none, treatment with one or multiple drug classes), HEUs had higher odds of any neurodevelopmental disorders compared with matched HUUs; however, there was no evidence suggesting any specific classes of antiretroviral drugs or exposure durations increased their likelihood of neurodevelopmental disorders.

CONCLUSION:

The results suggest no adverse associations between antiretroviral drugs and neurodevelopmental disorders within antiretroviral-exposed HEU children in our cohort. Prevalence of neurodevelopmental disorders is higher in HEUs; however, maternal substance use plays a role, as could other environmental factors not captured. These findings highlight a need for holistic support for pregnant women as well as careful developmental monitoring of HEUs past infancy, and access to early interventions, particularly among those born preterm and those exposed to addictive substances.
Assuntos

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 Base de dados: MEDLINE Assunto principal: Efeitos Tardios da Exposição Pré-Natal / Desenvolvimento Infantil / Antirretrovirais / Transtornos do Neurodesenvolvimento / Troca Materno-Fetal Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male / Newborn / Pregnancy País/Região como assunto: America do norte Idioma: En Revista: AIDS Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 Base de dados: MEDLINE Assunto principal: Efeitos Tardios da Exposição Pré-Natal / Desenvolvimento Infantil / Antirretrovirais / Transtornos do Neurodesenvolvimento / Troca Materno-Fetal Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male / Newborn / Pregnancy País/Região como assunto: America do norte Idioma: En Revista: AIDS Ano de publicação: 2018 Tipo de documento: Article